Menovasinum
Producer: JSC Himfarm Republic of Kazakhstan
Code of automatic telephone exchange: D04AB
Release form: Liquid dosage forms. Solution for external use.
General characteristics. Structure:
Active agents: menthol racemic or menthol of 2,5 g, novocaine of 1,0 g, anaesthesin of 1,0 g.
Excipient: alcohol of 70% to 100 ml.
Pharmacological properties:
The combined drug for external use. Has mestnoanesteziruyushchy effect. Menthol expands superficial vessels of skin, causing the feeling of a cool which is followed by analgetic effect and, thereby, strengthens anesthetic effect of anaesthesin and novocaine, facilitates an itch.
Indications to use:
- neuralgia, mialgiya, arthralgia
- pruritic dermatosis.
Route of administration and doses:
Outwardly. Painful sites of skin pound 2-3 times a day.
To apply on doctor's orders.
Side effects:
Local allergic reactions are possible.
At long use are possible: dizziness, general weakness, lowering of arterial pressure.
Interaction with other medicines:
Are not established.
Contraindications:
Hypersensitivity to drug components.
Overdose:
It is not revealed.
Storage conditions:
To store in the place protected from light, at a temperature from 8 °C to 18 °C. To store in the place, unavailable to children!
Issue conditions:
Without recipe
Packaging:
On 50 ml of liquid in bottles from glass melt with a screw mouth. Bottles together with the application instruction in the state and Russian languages place in boxes from a cardboard.